|
| Press Releases |
|
 |
|
| Tuesday, May 28, 2024 |
|
|
CR Pharmaceutical Armed with Leading Advantages Releases Growth Potential and Achieves High-quality Sustainable Development |
| China Resources Pharmaceutical Group Limited ("CR Pharmaceutical" or the "Group") (stock code: 3320.HK), recorded total revenue of RMB244,703.9 million last year, a 12.2% climb year-on-year, and net profit of RMB 7,775.0 million, a 16.8% increase year-on-year. more info >> |
|
| Monday, November 14, 2022 |
|
|
CR Pharmaceutical Becomes Constituent of MSCI China Index Once Again |
| China Resources Pharmaceutical Group Limited ("CR Pharmaceutical" or the "Group") (stock code: 3320) has announced that the Group will once again be included as a constituent stock of the MSCI China Index, which will become effective after the market close on 30 November 2022. more info >> |
|
| Monday, January 20, 2020 |
|
|
安捷證券第二輪藥品集採結果：降價主旋律不變，首推創新型龍頭 |
| 2020年01月17日，第二輪國家集採正式開標，結果如下：122家企業參與採購，33個(按通用名計)藥品的194個品規激烈厮殺，價格降幅超出市場預期。 more info >> |
|
| Tuesday, July 2, 2019 |
|
|
华润医药再度蝉联资本杰出中国企业成就奖 |
华润医药集团有限公司（「华润医药」或「集团」；股份编号：3320）欣然宣布，集团于《资本杂志》主办的第十四届「资本杰出中国企业成就奖」中再度获选为「资本杰出中国医药集团」，彰显集团在过去一年于业务上的杰出表现及其稳固的发展潜力。
more info >> |
|
|
華潤醫藥再度蟬聯資本傑出中國企業成就獎 |
華潤醫藥集團有限公司（「華潤醫藥」或「集團」；股份編號：3320）欣然宣佈，集團於《資本雜誌》主辦的第十四屆「資本傑出中國企業成就獎」中再度獲選為「資本傑出中國醫藥集團」，彰顯集團在過去一年於業務上的傑出表現及其穩固的發展潛力。
more info >> |
|
| Friday, August 25, 2017 |
|
|
华润医药中期业绩增长理想 实现收益约港币827亿元 |
| 华润医药集团有限公司（「华润医药」）或「集团」；股份编号：3320）公布截至2017年6月30日止年度（「期内」）的中期业绩。 more info >> |
|
|
華潤醫藥中期業績增長理想 實現收益約港幣827億元 |
| 華潤醫藥集團有限公司（「華潤醫藥」）或「集團」；股份編號：3320）公佈截至2017年6月30日止年度（「期內」）的中期業績。 more info >> |
|
|
China Resources Pharmaceutical Delivers Solid Interim Results; Half-year Revenue Reaches HK$82.7 Billion |
| China Resources Pharmaceutical Group Limited ("CR Pharmaceutical" or the "Group") (stock code: 3320), announced its interim results for the six months ended 30 June 2017 ("Reporting Period"). more info >> |
|
| Monday, March 20, 2017 |
|
|
华润医药全年业绩稳健增长 实现收益约港币1,567亿元 |
华润医药集团有限公司（「华润医药」）或「集团」；股份编号：3320）公布截至2016年12月31日止年度（「年内」）的全年业绩。
more info >> |
|
|
華潤醫藥全年業績穩健增長 實現收益約港幣1,567億元 |
華潤醫藥集團有限公司（「華潤醫藥」）或「集團」；股份編號：3320）公佈截至2016年12月31日止年度（「年內」）的全年業績。
more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
JDE Peet's 正式啟用 OMP 的 Unison Planning(TM)，大規模提升供應鏈價值
Apr 1, 2026 21:50 HKT/SGT
|
|
|
JDE Peet's 正式启用 OMP 的 Unison Planning(TM) 系统，大规模提升供应链价值
Apr 1, 2026 21:50 HKT/SGT
|
|
|
JDE Peet's Goes Live with OMP's Unison Planning(TM), Accelerating Supply Chain Value at Scale
Apr 1, 2026 21:50 HKT/SGT
|
|
|
Datavault AI Returns a Second Time for Exclusive Investor Forum at Mar-a-Lago
Apr 1, 2026 21:00: JST
|
|
|
GMG Verified by Advanced Carbons Council & Successful ISO9001 Audit
Apr 1, 2026 21:00 HKT/SGT
|
|
|
Datavault AI 再度現身馬阿拉戈，出席專屬投資者論壇
Apr 1, 2026 20:00 HKT/SGT
|
|
|
Datavault AI 再度亮相马阿拉戈，参加独家投资者论坛
Apr 1, 2026 20:00 HKT/SGT
|
|
|
Datavault AI Returns a Second Time for Exclusive Investor Forum at Mar-a-Lago
Apr 1, 2026 20:00 HKT/SGT
|
|
|
Four leading spring tech fairs will take place in April, featuring over 3,700 exhibitors
Apr 1, 2026 19:52: JST
|
|
|
Four leading spring tech fairs will take place in April, featuring over 3,700 exhibitors
Apr 1, 2026 18:52 HKT/SGT
|
|
|
True IDC Pushes "Security Economy", Breaking Ground on Mega Data Center in EEC with 77-Billion-Baht BOI Investment, Cementing Thailand's No. 1 Position
Apr 1, 2026 18:50 HKT/SGT
|
|
|
China Risun (01907.HK) Reports Strong 37.7% Net Profit Surge in 2025 Amid Industry Challenges
Apr 1, 2026 18:07 HKT/SGT
|
|
|
中國旭陽集團（01907.HK）積極面對行業變化 2025年淨利逆勢增長37.7%
Apr 1, 2026 17:50 HKT/SGT
|
|
|
中国旭阳集团（01907.HK）积极面对行业变化 2025年净利逆势增长37.7%
Apr 1, 2026 17:42 HKT/SGT
|
|
|
CTF Life Collaborates with the HKMC to Refer the Policy Reverse Mortgage Programme and the Reverse Mortgage Programme
Apr 1, 2026 16:20 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
